Evaluation of Sedation in COVID-19 ARDS

CompletedOBSERVATIONAL
Enrollment

114

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

December 15, 2020

Study Completion Date

April 1, 2021

Conditions
Prone PositionSevere Acute Respiratory Syndrome Coronavirus 2Hypnotics and SedativesPulmonary Ventilation
Interventions
OTHER

Treatment group

None, solely treatment documentation

Trial Locations (1)

60590

University Hospital Frankfurt, Frankfurt am Main

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Goethe University

OTHER